Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 2/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 12/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | F10 | P00742 | 1/20 | 0.34 |
| ▸ | CDK2 | P24941 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6834064 | 0.91 | ALB (0.42) | ALBHIF1AMCL1TP53POLB | |
| SCHEMBL6835759 | 0.87 | GPR27 (0.46) | ALBHIF1AMCL1 | |
| SCHEMBL6835695 | 0.86 | ALB (0.46) | ALBHIF1A | |
| SCHEMBL6835869 | 0.86 | HIF1A (0.41) | ALBHIF1A | |
| SCHEMBL6833770 | 0.85 | PTPN2 (0.40) | ALBHIF1AMCL1CDK2 | |
| SCHEMBL6834095 | 0.84 | GPR27 (0.46) | ALB | |
| SCHEMBL6833108 | 0.84 | HIF1A (0.39) | ALBHIF1ACDK2 | |
| SCHEMBL6834138 | 0.84 | HIF1A (0.46) | ALBHIF1AF10CDK2 | |
| SCHEMBL6833193 | 0.84 | ALB (0.42) | ALBHIF1AMCL1TP53POLB | |
| SCHEMBL6834155 | 0.83 | F2 (0.50) | ALBHIF1AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | GABRD, GABBR1, GABRA1 | ALB 1417/4885HIF1A 220/4885MCL1 2086/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.